Resolution of fibrinogen deficiency in a patient with congenital afibrinogenemia after liver transplantation
Nicolas Gallastegui(The Ohio State University), Thomas J. Harrington(University of Miami), Erik L. Kimble(University of Washington)
Cited by 9
Related Papers
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies
|Blood|2020|217
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy
|Transplantation and Cellular Therapy|2023|144
Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution
|Journal of Clinical Oncology|2018|79
Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients
|Transplantation and Cellular Therapy|2017|72